Combined Ramipril and Black Seed Oil Dosage Forms Using Bioactive Self-Nanoemulsifying Drug Delivery Systems (BIO-SNEDDSs)

Abstract

Purpose: Ramipril (RMP)—an angiotensin-converting enzyme (ACE) inhibitor—and thymoquinone (THQ) suffer from poor oral bioavailability. Developing a combined liquid SNEDDS that comprises RMP and black seed oil (as a natural source of THQ) could lead to several formulations and therapeutic benefits. Methods: The present study involved comprehensive optimization of RMP/THQ liquid SNEDDS using self-emulsification assessment, equilibrium solubility studies, droplet size analysis, and experimentally designed phase diagrams. In addition, the optimized RMP/THQ SNEDDS was evaluated against pure RMP, pure THQ, and the combined pure RMP + RMP-free SNEDDS (capsule-in-capsule) dosage form via in vitro dissolution studies. Results: The phase diagram study revealed that black seed oil (BSO) showed enhanced self-emulsification efficiency with the cosolvent (Transcutol P) and hydrogenated castor oil. The phase diagram studies also revealed that the optimized formulation BSO/TCP/HCO-30 (32.25/27.75/40 % w/w) showed high apparent solubility of RMP (25.5 mg/g), good THQ content (2.7 mg/g), and nanometric (51 nm) droplet size. The in-vitro dissolution studies revealed that the optimized drug-loaded SNEDDS showed good release of RMP and THQ (up to 86% and 89%, respectively). Similarly, the isolation between RMP and SNEDDS (pure RMP + RMP-free SNEDDS) using capsule-in-capsule technology showed >84% RMP release and >82% THQ release. Conclusions: The combined pure RMP + RMP-free SNEDDS (containing black seed oil) could be a potential dosage form combining the solubilization benefits of SNEDDSs, enhancing the release of RMP/THQ along with enhancing RMP stability through its isolation from lipid-based excipients during storage.

Optimization of Gefitinib-Loaded Nanostructured Lipid Carrier as a Biomedical Tool in the Treatment of Metastatic Lung Cancer

“…Analysis of variance (ANOVA) was applied to determine the significance of each design model, independent variables, and their interactions [ 45 ]. For each response, the optimum model was selected based on whether it showed a high correlation coefficient, a high F-value, a non-significant lack of fit, high adjusted and predicted R2 (difference < 0.2), and high adequate precision [ 46 , 47 ]. Response surfaces were constructed using the obtained equations to aid in the selection of the optimized formulation based on PS, PDI, and ZP.…”

Adsorbent Precoating by Lyophilization: A Novel Green Solvent Technique to Enhance Cinnarizine Release from Solid Self-Nanoemulsifying Drug Delivery Systems (S-SNEDDS)

“…These studies could help to understand the predominant mechanism of incomplete drug release from freshly prepared and stored S-SNEDDS. In addition, future studies could explore the significance of the physical separation between CN solid dispersion and drug-free cured S-SNEDDS (through capsule-in-capsule technology) on CN release and stability within the formulation [ 2 , 39 ]. Finally, further in vivo pharmacokinetic and pharmacodynamic studies should be conducted to correlate the formulation in vitro findings with the in vivo performance.…”

Assembly of nanostructured lipid carriers loaded gefitinib and simvastatin as hybrid therapy for metastatic breast cancer: Codelivery and repurposing approach

“…Analysis of variance (ANOVA) was applied to determine the significance of each design model, independent variables, and their interactions (Valicherla et al, 2016). A strong correlation coefficient, high F ‐value, nonsignificant lack of fit, high adjusted and anticipated R , 2 and high acceptable precision were used to choose the best model for each response (Mukherjee & Plakogiannis, 2010; Shahba et al, 2022). Response surfaces were constructed using the obtained equations to aid in the selection of the optimized formulation based on PS, PDI, ZP, EE (GFT), DL (GFT), EE (SIM), and DL (SIM).…”